LXRα is involved in the control of lipid homeostasis and inflammation, while the activation of LXRα-related downstream targets has beneficial effects in pathologic conditions, such as atherosclerosis [46], inflammation [47], and AD [48]. Here, NR1H3 is linked to Alzheimer disease.